The global orthobiologics market is expected to grow from $4.66 billion in 2017 to reach $8.06 billion by 2023, increasing at a 5.7 percent compound annual growth rate, according to a Market.Biz report.
The major players in the global orthobiologics market include:
1. Stryker
2. RTI Surgical
3. Bioventus
4. Zimmer Biomet
5. Seaspine
6. Kuros Biosciences
7. Globus Medical
8. Xtant Medical
9. Harvest Technologies
10. Nuvasive
11. Orthofix International
12. Arthrex
13. Medtronic
14. K2M
15. DePuy Synthes
More articles on biologics:
Tissue Regenix group inks deal, expands DermaPure access in US
Biologica Technologies to exhibit ProteiOS data at AANS Annual Meeting: 3 insights